AST SpaceMobile selected Blue Origin's New Glenn together with existing launch vehicles to launch next generation BlueBird ...

Bluebird reports 17 people with sickle cell disease started receiving Lyfgenia gene therapy, with 35 starting Zynteglo for ...

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported third quarter results and business highlights for the quarter ended September 30, 2024, including recent commercial ...

With a rich background in finance and experience in the pharmaceutical sector, including roles at bluebird bio and Jubilant Pharma, Krawtschuk is expected to bring valuable insight to Eagle’s ...

Eagle Pharmaceuticals (EGRX) announced the appointment of Christopher ... Most recently, Mr. Krawtschuk served as CFO and Treasurer of bluebird bio. Published first on TheFly – the ultimate source for ...